C. Nacci

发表

Elevated endothelin-1 (ET-1) levels may contribute to hypoadiponectinemia in childhood obesity.

N. Bartolomeo, P. Giordano, M. Faienza, 2013, The Journal of clinical endocrinology and metabolism.

Endothelial Dysfunction May Link Interatrial Septal Abnormalities and MTHFR-Inherited Defects to Cryptogenic Stroke Predisposition

M. Ciccone, A. Bortone, E. de Cillis, 2020, Biomolecules.

Activation of AMPK/SIRT1 axis is required for adiponectin-mediated preconditioning on myocardial ischemia-reperfusion (I/R) injury in rats

C. Nacci, V. Leo, M. Montagnani, 2019, PloS one.

Immunoregulatory effects of L-arginine and therapeutical implications.

C. Nacci, M. Potenza, D. Mitolo-chieppa, 2001, Current Drug Targets - Immune, Endocrine & Metabolic Disorders.

The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value

A. Vacca, V. Desantis, M. Frassanito, 2022, Journal of clinical medicine.

Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-κB/COX-2 signaling in human aortic endothelial cells.

M. Quon, F. Addabbo, C. Nacci, 2011, American journal of physiology. Endocrinology and metabolism.

Chronic treatment with epigallocatechin gallate reduces motor hyperactivity and affects in vitro tested intestinal motility of spontaneously hypertensive rats

C. Nacci, M. Montagnani, M. Potenza, 2016, Food & nutrition research.

Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.

M. Quon, C. Nacci, L. De Benedictis, 2009, Endocrinology.

Functional characterization of endothelin receptors in hypertensive resistance vessels.

M. Serio, A. Pirrelli, C. Nacci, 1999, Journal of hypertension.

Carbon monoxide contributes to the constipating effects of granisetron in rat colon

C. Nacci, V. Leo, M. Montagnani, 2016, World journal of gastroenterology.

Endothelial COX-1 and -2 differentially affect reactivity of MVB in portal hypertensive rats.

R. Andriantsitohaina, O. A. Botrugno, C. Nacci, 2002, American journal of physiology. Gastrointestinal and liver physiology.

Endothelin‐1‐receptor‐mediated responses in resistance vessels of young and adult spontaneously hypertensive rats

P. Nazzaro, A. Pirrelli, C. Nacci, 2000, Journal of hypertension.

Effects of in vivo treatment with interleukins 1beta and 6 on rat mesenteric vascular bed reactivity.

C. I. Mitolo, C. Nacci, L. Natale, 2003, Autonomic & autacoid pharmacology.

Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.

C. Nacci, M. Carratù, M. Montagnani, 2009, Current medicinal chemistry.

Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice

R. Andriantsitohaina, J. Ménissier-de murcia, G. de Murcia, 1999, The EMBO journal.

Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?

V. Desantis, C. Nacci, M. Montagnani, 2021, Antioxidants.

In vitro effects of 3'-azido-3'-deoxythymidine (AZT) on normal human polymorphonuclear cell and monocyte-macrophage functional capacities.

R. Calvello, C. De Simone, E. Jirillo, 1996, Immunopharmacology and immunotoxicology.

Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?

Barbara Pasculli, C. Nacci, M. Montagnani, 2019, International journal of molecular sciences.

Galloyl benzamide‐based compounds modulating tumour necrosis factor α‐stimulated c‐Jun N‐terminal kinase and p38 mitogen‐activated protein kinase signalling pathways

F. Leonetti, A. Carotti, A. Stefanachi, 2015, The Journal of pharmacy and pharmacology.

microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation

V. Desantis, S. Cicco, Antonio Giovanni Solimando, 2023, International journal of molecular sciences.

Infliximab therapy restores adiponectin expression in perivascular adipose tissue and improves endothelial nitric oxide-mediated vasodilation in mice with type 1 diabetes.

M. Quon, C. Nacci, V. Leo, 2016, Vascular pharmacology.

Stress, neuropsychiatric disorders and immunological effects exerted by benzodiazepines.

E. Jirillo, A. B. Maffione, C. Nacci, 1998, Immunopharmacology and immunotoxicology.

Idiopathic chronic constipation: tachykinins as cotransmitters in colonic contraction

V. Memeo, D. Altomare, M. Rinaldi, 2001 .

Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options

M. Collino, C. Nacci, M. Montagnani, 2017, Pharmacological research.

Molecular and clinical aspects of endothelial dysfunction in diabetes

C. Nacci, M. Montagnani, M. Tarquinio, 2009, Internal and emergency medicine.

Endothelial and Metabolic Function Interactions in Overweight/Obese Children.

P. Giordano, A. Zito, P. Scicchitano, 2016, Journal of atherosclerosis and thrombosis.

In Vivo Effects of Recombinant-Interferon-β1b Treatment on Polymorphonuclear Cell and Monocyte Functions and On T-Cell-Mediated Antibacterial Activity in Patients with Relapsing-Remitting Multiple Sclerosis

P. Livrea, M. Troiano, E. Jirillo, 2000, Immunopharmacology and immunotoxicology.

IN MVO EFFECTS OF RECOMBINANT-1NTERFERON-C)lb FUNCTIONS AND ON T-CELLMEDIATED ANTIBACTERIAL TREATMENT ON POLYMORPHONUCLEAR CELL AND MONOCYTE ACTIVITY IN PATIENTS WITH RELAPSINGREMITTING MULTIPLE SCLEROSIS

E. Jirillo, V. Mitolo, C. Nacci, 2000 .

Galloyl benzamide‐based compounds modulating tumour necrosis factor α‐stimulated c‐Jun N‐terminal kinase and p38 mitogen‐activated protein kinase signalling pathways

F. Leonetti, A. Carotti, A. Stefanachi, 2015, The Journal of pharmacy and pharmacology.

Endothelial Dysfunction in Diabetes: An Update on Mechanisms and Therapeutic Targets

C. Nacci, V. Leo, M. Montagnani, 2016 .

Cardiovascular complications in diabetes: lessons from animal models.

C. Nacci, M. Montagnani, S. Gagliardi, 2011, Current medicinal chemistry.